RWMCX
Price
$66.91
Change
+$0.45 (+0.68%)
Updated
Oct 24 closing price
Net Assets
209.78B
VTSMX
Price
$162.41
Change
+$1.29 (+0.80%)
Updated
Oct 24 closing price
Net Assets
2.02T
Interact to see
Advertisement

RWMCX vs VTSMX

Header iconRWMCX vs VTSMX Comparison
Open Charts RWMCX vs VTSMXBanner chart's image
American Funds Washington Mutual R3
Price$66.91
Change+$0.45 (+0.68%)
VolumeN/A
Net Assets209.78B
Vanguard Total Stock Mkt Idx I
Price$162.41
Change+$1.29 (+0.80%)
VolumeN/A
Net Assets2.02T
RWMCX vs VTSMX Comparison Chart in %
View a ticker or compare two or three
VS
RWMCX vs. VTSMX commentary
Oct 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RWMCX is a StrongBuy and VTSMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 2.02T vs. RWMCX (210B). VTSMX pays higher dividends than RWMCX: VTSMX (1.04) vs RWMCX (0.90). RWMCX was incepted earlier than VTSMX: RWMCX (23 years) vs VTSMX (34 years). RWMCX (0.91) is less costly to investors than VTSMX (0.14). RWMCX is a more actively managed with annual turnover of: 29.00 vs. VTSMX (2.00). RWMCX has a lower initial minimum investment than VTSMX: RWMCX (250) vs VTSMX (3000). VTSMX annual gain was more profitable for investors over the last year : 16.88 vs. RWMCX (6.20). VTSMX return over 5 years is better than : 89.39 vs. RWMCX (49.46).
RWMCXVTSMXRWMCX / VTSMX
Total Expense Ratio0.910.14650%
Annual Report Gross Expense Ratio0.910.14650%
Fund Existence23 years34 years-
Gain YTD10.87215.25571%
Front LoadN/AN/A-
Min. Initial Investment25030008%
Min. Initial Investment IRAN/AN/A-
Net Assets210B2.02T10%
Annual Yield % from dividends0.901.0487%
Returns for 1 year6.2016.8837%
Returns for 3 years36.8773.4350%
Returns for 5 years49.4689.3955%
Returns for 10 years73.54227.6232%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XFOR3.800.71
+22.98%
X4 Pharmaceuticals Inc
TRIB1.000.05
+5.67%
Trinity Biotech plc
CCOI42.960.24
+0.56%
Cogent Communications Holdings
MANH194.850.17
+0.09%
Manhattan Associates
EQV10.44N/A
N/A
EQV Ventures Acquisition Corp